United Kingdom· GB-APID-36869911000001105
Olmesartan medoxomil 20mg tablets
A medicinal product containing olmesartan, registered in United Kingdom by Torrent Pharma (UK) Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Olmesartan
- Manufacturer
- Torrent Pharma (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5060623370473
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Olmesartan in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d8f0bb67-60ea-410b-8799-d5fd97f987d0 GET /v1/drugs/d8f0bb67-60ea-410b-8799-d5fd97f987d0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "36869911000001105",
"desc": "Olmesartan medoxomil 20mg tablets (Torrent Pharma (UK) Ltd)",
"form": "Oral tablet",
"vpid": "42378411000001103",
"source": "dmd",
"vtm_id": "776982004",
"strength": "20 mg",
"substance": "Olmesartan",
"ingredient": "Olmesartan medoxomil",
"supplier_code": "31535811000001105"
}See everything about olmesartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.